| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $127.6M | +25.1% |
| Cost of Revenue | $58.3M | +11.7% |
| Gross Profit | $69.3M | +39.1% |
| R&D Expense | $42.1M | +6.5% |
| SG&A Expense | $29.1M | +7.9% |
| Operating Income | -$46.3M | +20.1% |
| Pre-tax Income | -$48.5M | +18.7% |
| Income Tax | $6K | — |
| Net Income | -$48.5M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $45.8M | +266.1% |
| Short-term Investments | $9.1M | -45.6% |
| Accounts Receivable | $1.8M | +128.9% |
| Current Assets | $65.7M | +70.7% |
| Total Assets | $168.6M | +28.0% |
| Current Liabilities | $59.8M | +4.8% |
| Total Liabilities | $90.9M | +4.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $12.5M | +270.1% |
| Capital Expenditures | $1.7M | -69.0% |
| Investing Cash Flow | -$6.1M | -128.3% |
| Financing Cash Flow | $22.8M | +357.5% |
| Free Cash Flow | $10.8M | +183.9% |
| +18.7% |
| EPS (Basic) | -$1.11 | +33.1% |
| EPS (Diluted) | -$1.11 | +33.1% |
| Stockholders' Equity |
| $77.6M |
| +72.7% |